Practical problems and resource implications with the use of warfarin for venous thromboembolism in patients with cancer
✍ Scribed by P. G. Morris; C. Davenport; D. O’Dwyer; C. O’Callaghan; O. S. Breathnach; L. Grogan
- Book ID
- 107525978
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 201 KB
- Volume
- 176
- Category
- Article
- ISSN
- 1863-4362
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology
## Abstract Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk occurring during hospitalization and after disease recurrence. Patient and disease characteristics are